🔎 Trials Near Me

Utama › Diabetes Jenis 2 › Alabama

Kajian klinikal Diabetes Jenis 2 di Alabama

22 kajian untuk Diabetes Jenis 2 sedang mencari peserta di lokasi di Alabama.

Bandar di Alabama

Teks kajian rasmi (Bahasa Inggeris)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

  • University of Alabama, Birmingham
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06906640

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  • University of Alabama, Birmingham
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06906627

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Heart Center Research, LLC, Huntsville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Pinnacle Research Group, LLC, Anniston
  • Eastern Shore Research Group, Fairhope
  • Lakeview Clinical Research, Guntersville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Cahaba Research, Inc. - Trussville Location, Birmingham
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07754461

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Birmingham Clinical Research, Birmingham
  • Cullman Clinical Trials, Cullman
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Fairhope
  • Research Site, Huntsville
  • Research Site, Mobile
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Birmingham
  • AURORA-2 Clinical Site, Huntsville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • Central Research Associates - Flourish - PPDS, Birmingham
  • AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
  • AES - DRS - Optimal Research Alabama - Huntsville, Huntsville
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Lakeview Clinical Research, Guntersville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07351058

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Apogee Clinical Research, LLC, Huntsville
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

  • Flourish Research, Birmingham
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07668388

Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)

  • UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
Mengambil peserta
Umur 18 hingga 89 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07032844

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Univ of Alabama Birmingham, Birmingham
  • Eastern Shore Rsrch Inst, LLC, Fairhope
  • Chambliss Clinical Trials, LLC, Montgomery
Mengambil pesertaFasa 3
Umur 45 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Huntsville
  • Research Site, Mobile
  • Research Site, Sheffield
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT07662109

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  • Research Site, Birmingham
  • Research Site, Daphne
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT07662044

CGM for Management of Type 2 Diabetes in Pregnancy

  • University of Alabama at Birmingham, Birmingham
Mengambil peserta
Umur 18 hingga 50 · Wanita · Dikemas kini 29 Jun 2026 · NCT06628453

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

  • Central Research Associates, LLC dba Flourish Research, Birmingham
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 15 Jun 2026 · NCT07502508

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

  • University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatian
Umur 8 hingga 15 · Semua jantina · Dikemas kini 7 Mei 2026 · NCT06525259

FELLAShip to Better Health

  • The Worship Center Cristian Church, Birmingham
Mengambil peserta
Umur 18 ke atas · Lelaki · Dikemas kini 22 Jan 2026 · NCT07220213

A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients

  • University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Mengambil peserta
Umur 12 hingga 18 · Semua jantina · Dikemas kini 8 Dis 2025 · NCT06902077

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.